Research building

3.3. Cost-effectiveness of personalised diabetes treatment

Research
Relevance

How our research benefits to society

This project aims at enlightening issues on health economics and precision medicine in diabetes treatment and prevention, with specific reference to reimbursement of new drugs. Notably, diabetes is involved with various risk factors for onset and complications, including genetics (family history), life style and BMI. Additionally, situational issues come in concerning comorbidities, polypharmacy and adherence to therapies. Known biomarkers concern blood sugar levels and Hb1Ac, but also nephropathic complication-related biomarkers such as albumin.

This project is part of